Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Blood drug"'
Autor:
P. N. Vlasov
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 9, Iss 3, Pp 98-104 (2017)
Many antiepileptic drugs (AEDs) have a short half-life (T1/2) with a wide fluctuation from peak to trough blood concentrations. According to this pharmacokinetic profile, there may be both adverse events (AEs) due to the increase in a blood drug conc
Autor:
Richard M. Weinshilboum, Meenal Gupta, Anthony Batzler, Joanna M. Biernacka, Drew Neavin, Yusuke Nakamura, Wayne R. Matson, Michelle K. Skime, William V. Bobo, Duan Liu, Mark A. Frye, Hongjie Zhu, Krishna R. Kalari, Greg D. Jenkins, Liewei Wang, Daniel K. Hall-Flavin, T Mushiroda, Swati S. Bhasin, Michiaki Kubo, Rima Kaddurah-Daouk
Publikováno v:
Molecular Psychiatry
Millions of patients suffer from major depressive disorder (MDD), but many do not respond to selective serotonin reuptake inhibitor (SSRI) therapy. We used a pharmacometabolomics-informed pharmacogenomics research strategy to identify genes associate
Publikováno v:
Journal of Clinical Psychopharmacology. 33:415-419
In acute psychiatric services, rapid and accurate detection of psychoactive substance intake may be required for appropriate diagnosis and intervention. The aim of this study was to investigate the relationship between (a) drug influence as assessed
Publikováno v:
Addiction. 107:925-932
Aims To investigate individual traffic-relevant impairment related to measured blood zopiclone and ethanol concentrations. Also, we aimed to study possible development of acute tolerance. Design A randomized controlled four-way cross-over double-blin
Autor:
Maureen S. Drews, Jessica Sagen, Victor M. Karpyak, Barbara M. Rohland, David J. Katzelnick, Astrid A. Hoberg, Donald E. McAlpine, Michelle K. Skime, Karen Snyder, Victoria Passov, Mark D. Williams, David A. Mrazek, Daniel J. Schaid, Gen Shinozaki, Richard M. Weinshilboum, Pamela J. Netzel, Daniel K. Hall-Flavin, Joachim Benitez, Joanna M. Biernacka
The decision regarding whether to initiate treatment with an SSRI for patients with depression is a common and important question for both patients and clinicians. Multiple clinical efficacy trials have demonstrated superiority of antidepressants to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d119b98ebb62549cce2e49b90282cf24
https://europepmc.org/articles/PMC3992481/
https://europepmc.org/articles/PMC3992481/
WOS: 000334279100007
Objective: The aim of the present study is to adapt the Morisky Medication Adherence Scale (MMAS) to Turkish, examine the reliability and validity of the scale among bipolar mood disorder patients and examine the relationshi
Objective: The aim of the present study is to adapt the Morisky Medication Adherence Scale (MMAS) to Turkish, examine the reliability and validity of the scale among bipolar mood disorder patients and examine the relationshi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::431c14c8b025f3064e87233a787c718f
https://hdl.handle.net/20.500.12628/3254
https://hdl.handle.net/20.500.12628/3254
Publikováno v:
The Journal of Clinical Psychiatry. 60:584-590
BACKGROUND We report the results of an open trial of cognitive-behavioral therapy (CBT) using exposure and ritual prevention as an adjunct to serotonin reuptake inhibitors (SRIs) in obsessive-compulsive disorder (OCD). We hypothesized that exposure a
Publikováno v:
The Journal of Clinical Psychiatry. 59:657-663
Background The purpose of this study was to compare the overall effectiveness of 2 treatment strategies for inpatients with severe major depressive episode (DSM-III-R): (1) mirtazapine (phase 1) and subsequent lithium addition (phase 2) or (2) imipra
Autor:
Malcolm Lader, Nedzara Jusic
Publikováno v:
British Journal of Psychiatry. 165:787-791
BackgroundThe relationship between antipsychotic drug treatment and sudden unexplained death remains unclear. The estimation of post-mortem blood drug concentrations should be helpful.MethodEight medico-legal cases were reviewed with respect to behav
Autor:
Ronald Gieschke, P. van Brummelen, J. van den Krogt, Peter C. Chang, S. Wijnands, M.-P. Schoerlin, G. J. Blauw
Publikováno v:
Journal of psychopharmacology (Oxford, England). 3(1)
The interaction between tyramine and the new short-acting and reversible mono amine oxidase inhibitor moclobemide was investigated in a double-blind placebo-controlled study in six healthy volunteers. There were two consecutive study periods of 8 day